Fig. 1.

Mean (SE) haemoglobin (Hb) level from baseline (BL) through to week 79, then last on-treatment visit with available assessment (LV). Only non-missing values are considered. LV is the last on-treatment visit with available assessment. Two data points in the sutimlimab-to-sutimlimab group at week 61 and 67 showed a greater mean (SE) level of Hb than at the other time points ie, 13.3 g/dL (1.6) and 13.4 g/dL (1.6). Both data points were attributed to the same patient. PBO, placebo. SE, standard error. SUT, sutimlimab.